One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension

Diabetic Medicine

Volumn 33, Issue 8, 2016, Pages 1060-1066

  Bergman, M ^a   Chetrit, A ^b   Roth, J ^c   Dankner, R ^b,c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH HAZARD; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MORTALITY RISK; NORMAL VALUE; ORAL GLUCOSE TOLERANCE TEST; PROGNOSIS; SEX; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84978827322     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13116     Document Type: Article

References (20)

1. Joshipura KJ, Andriankja MO, Ritchie CS. Relative utility of 1-hr oral glucose tolerance test as a measure of abnormal glucose homeostasis. Diabetes Res Clin Pract 2011; 93: 268–275.
2. Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008; 31: 1650–1655.
3. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009; 32: 281–286.
4. Bergman M, Chetrit A, Roth J, Dankner R. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension. Diabetes Metab Res Rev 2015; 31: 368–375.
5. Orencia AJ, Daviglus ML, Dyer AR, Walsh M, Greenland P, Stamler J. One-hour post load plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol 1997; 50: 1369–1376.
6. Modan M, Halkin H, Karasik A, Lusky A. Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol 1984; 119: 431–444.
7. Modan M, Karasik A, Halkin H, Fuchs Z, Lusky A, Shitrit A et al. Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response. The Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabetologia 1986; 29: 82–89.
8. Modan M, Halkin H, Fuchs Z, Lusky A, Chetrit A, Segal P et al. Hyperinsulinemia – a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance. Diabete Metab 1987; 3: 375–380.
9. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–1057.
10. Cerasi E, Efendic S, Luft R. Dose response relation between plasma-insulin and blood glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 1973; i: 794–797.
11. Manual of Laboratory Operations. Lipid Research Clinics Program. Volume 1. Lipid and Lipoprotein Analysis. Bethesda, MD: National Heart and Lung Institute, National Institutes of Health. DHEW Publication No. (NIH) 75-628.
12. Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine 2014; 2015: 371–393.
13. Bergman M, Dankner R, Roth J, Venkat Narayan KM. Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches. Viewpoint. Endocrine 2013; 44: 66–69.
14. Manco M, Panunzi S, Macfarlane DP, Golay A, Melander O, Konrad T et al. One-hour plasma glucose identifies insulin resistance and β-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care 2010; 33: 2090–2097.
15. Alyass A, Almgren P, Akerlund M, Dushoff J, Isomaa B, Nilsson P et al. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia 2015; 58: 87–97.
16. Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, Andreozzi F et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 2009; 207: 245–249.
17. Sciacqua A, Miceli S, Carullo G, Greco L, Succurro E, Arturi F et al. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 2011; 34: 1406–1411.
18. Sciacqua A, Maio R, Miceli S, Pascale A, Carullo G, Grillo N et al. Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS One 2012; 7: e44470.
19. Metter EJ, Windham BG, Maggio M, Simonsick EM, Ling SM, Egan JM et al. Glucose and insulin measurements from the glucose tolerance test and mortality prediction. Diabetes Care 2008; 31: 1026–1030.
20. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150: 341–353.